You have 9 free searches left this month | for more free features.

Condition

AML, Adult Recurrent (1)

Cholangiocarcinoma (1)

Colorectal Cancer (1)

MDS (1)

Metastatic Cancer (1)

Pancreatic Cancer (1)

Solid Tumor (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

PureTech (2)

Collaborator

Intervention

lyt-200 (2)

anti-pd-1 (1)

gemcitabine/nab-paclitaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

lyt-200

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting

AML, Adult Recurrent
MDS

LYT-200

Los Angeles, California
+13 more

Apr 12, 2023

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting

Metastatic Cancer
+4 more

LYT-200
+2 more

Phoenix, Arizona
+15 more

Mar 9, 2022